Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Teleflex Incorporated    TFX

TELEFLEX INCORPORATED

(TFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Teleflex Incorporated : Stephens Investment Conference 2020

11/16/2020 | 12:55pm EST

Teleflex Investor Presentation

Forward Looking Statements

This presentation and our discussion contain forward-looking information and statements, which inherently involve risks and uncertainties that could cause actual results to differ from those projected or implied in the forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements, including those risks and uncertainties discussed in our SEC filings, including our most recent Annual Report on Form 10-K. The forward-looking statements included in this presentation should not be unduly relied upon. These statements speak only as of the date made. Other than as required by applicable law, we do not intend, and do not assume any obligation, to update these forward-looking statements.

This presentation reflects continuing operations.

2

Making a Difference

Teleflex products are used everyday:

31,000

In 31,000 surgical procedures in the United States

1,600

To help more than 1,600 patients who require vascular access intervention globally

6,000

To care for more than 6,000 patients globally in the Intensive Care Unit

3,200

By emergency responders to treat 3,200 patients in the field globally

3

Statistics included in the graphic above were calculated based on 2016 sales data, and management assumptions and estimates

Demographics and Industry Trends in Our Favor

10,000

People turn 65 in the

U.S. everyday1

Lower acuity patients

1.1B

moving to lower cost

sites of service

People 50+

in Asia by 20252

4 1. Pew Research Center: http://www.pewresearch.org/fact-tank/2010/12/29/baby-boomers-retire/

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Teleflex Inc. published this content on 16 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 November 2020 17:54:04 UTC


© Publicnow 2020
All news about TELEFLEX INCORPORATED
01/20Published Data Demonstrate Sexual Function Improvement and Preservation with ..
GL
01/19Teleflex continues to deliver COMPLETE confidence with new Arrow® ErgoPack® C..
GL
01/08TELEFLEX INCORPORATED : KeyBanc Adjusts Price Target on Teleflex to $441 From $3..
MT
01/06TELEFLEX INCORPORATED : Needham Adjusts Teleflex' Price Target to $445 from $406..
MT
01/04Teleflex to Present at the 39th Annual J.P. Morgan Healthcare Conference
GL
2020INSIDER TRENDS : Teleflex Insider Exercises Option/Derivative Security to Acquir..
MT
2020TELEFLEX INCORPORATED : Acquires Z-Medica
MT
2020DW HEALTHCARE PARTNERS : and Linden Announce Sale of Z-Medica to Teleflex
PR
2020Teleflex Completes Acquisition of Market Leader in Hemostatic Products
GL
2020TELEFLEX INCORPORATED : SVB Leerink Adjusts Teleflex' Price Target to $450 from ..
MT
More news
Financials (USD)
Sales 2020 2 512 M - -
Net income 2020 345 M - -
Net Debt 2020 1 792 M - -
P/E ratio 2020 50,7x
Yield 2020 0,36%
Capitalization 17 995 M 17 995 M -
EV / Sales 2020 7,88x
EV / Sales 2021 6,88x
Nbr of Employees 14 400
Free-Float 97,3%
Chart TELEFLEX INCORPORATED
Duration : Period :
Teleflex Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TELEFLEX INCORPORATED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Average target price 418,58 $
Last Close Price 386,44 $
Spread / Highest target 21,6%
Spread / Average Target 8,32%
Spread / Lowest Target -50,3%
EPS Revisions
Managers and Directors
NameTitle
Liam J. Kelly Chairman, President & Chief Executive Officer
Thomas E. Powell Chief Financial Officer & Executive Vice President
Timothy F. Duffy Chief Information Officer & Vice President
Michelle Fox Chief Medical Officer & Vice President
George Babich Lead Independent Director
Sector and Competitors